Deshpande N, Mitchell I
J Endocrinol. 1980 Jun;85(3):415-21. doi: 10.1677/joe.0.0850415.
The possible involvement of opioids in carbohydrate metabolism in rat mammary glands was investigated by studying the effects of administration of morphine and naloxone on six enzymes. Morphine inhibited phosphofructokinase (PFK) and stimulated phosphohexose isomerase (PHI) activities. Nalozone treatment alone, to both intact and ovariectomized/adrenalectomized animals, resulted in stimulation of PFK and inhibition of PHI activities. A combined dose of morphine and naloxone to intact animals showed that the opiate antagonist was able to reverse the morphine-induced changes. Evidence is presented to show that the changes observed in PHI activity may be the result of the indirect action of opioids on luteinizing hormone releasing hormone. However, the changes observed in PFK activity might be the result of direct action of opioids. Failure to observe changes in enzyme acstivities after naloxone treatment of hypophysectomized animals suggests the opiate antagonist might be acting on the pituitary gland to block the release of endorphins.
通过研究吗啡和纳洛酮给药对六种酶的影响,调查了阿片类药物在大鼠乳腺碳水化合物代谢中可能的参与情况。吗啡抑制磷酸果糖激酶(PFK)并刺激磷酸己糖异构酶(PHI)活性。单独给完整动物以及去卵巢/肾上腺切除动物注射纳洛酮,会导致PFK活性增强和PHI活性抑制。给完整动物联合使用吗啡和纳洛酮的剂量表明,阿片类拮抗剂能够逆转吗啡诱导的变化。有证据表明,观察到的PHI活性变化可能是阿片类药物对促黄体生成素释放激素间接作用的结果。然而,观察到的PFK活性变化可能是阿片类药物直接作用的结果。对垂体切除动物注射纳洛酮后未观察到酶活性变化,这表明阿片类拮抗剂可能作用于垂体以阻断内啡肽的释放。